Sign in
4

Changes in Ownership

TransMedics Group, Inc. Filed Acc 0000950170-23-005194

Director sold 5,934 shares at an average $76.69 ($455,100)

  • Director acquired 5,934 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Weill David Director 2023-02-27 Option exercise +5,934 $14.20 $84,263 15,934 D: show line 1 in the form
Weill David Director 2023-02-27 Sale −964 $77.64 $74,845 14,970 D: show line 2 in the form
Weill David Director 2023-02-27 Sale −4,970 $76.51 $380,255 10,000 D: show line 3 in the form
Open-market sales · 5,934 sh · avg $76.69 · $455,100

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Weill David Director 2023-02-27 Option exercise · Stock Option (Right to Buy) −5,934 10,000 D: show line 4 in the form
Loading xslF345X03/ownership.xml…